Advertisement
Screener

ANI PHARMACEUTICALS, INC (ANIP) Net Margin

ANI PHARMACEUTICALS, INC (ANIP) Net Margin

  • 2026-06-30: Net Margin 9.29%.
  • 2026-03-31: Net Margin 12.42%.
  • 2025-12-31: Net Margin 11.13%.
  • 2025-09-30: Net Margin 11.68%.

Complete source-backed net margin history.

Available history
2010-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-309.29%
2026-03-3112.42%
2025-12-3111.13%
2025-09-3011.68%
2025-06-304.04%
2025-03-317.95%
2024-12-31-5.39%
2024-09-30-16.29%
2024-06-30-1.66%
2024-03-3113.25%
2023-12-310.88%
2023-09-307.54%
2023-06-305.36%
2023-03-311.35%
2022-12-31-4.50%
2022-09-30-10.26%
2022-06-30-20.21%
2022-03-31-31.22%
2021-12-31-39.61%
2021-09-30-8.54%
2021-06-30-29.01%
2021-03-310.16%
2020-12-31-6.35%
2020-09-300.82%
2020-06-30-25.45%
2020-03-31-14.09%
2019-12-31-10.08%
2019-09-307.59%
2019-06-3012.11%
2019-03-310.85%
2018-12-319.51%
2018-09-309.93%
2018-06-305.88%
2018-03-314.84%
2017-12-31-20.36%
2017-09-309.80%
2017-06-305.99%
2017-03-313.15%
2016-12-31-2.83%
2016-09-306.60%
2016-06-303.59%
2016-03-316.55%
2015-12-3115.95%
2015-09-3022.83%
2015-06-3018.30%
2015-03-3123.24%
2014-12-3199.85%
2014-09-3038.80%
2014-06-30-35.55%
2014-03-3130.82%
2013-12-3132.60%
2013-09-3015.20%
2013-06-30-74.50%
2013-03-314.67%
2012-12-31-21.70%
2012-09-30-7.49%
2012-06-300.68%
2011-09-30-6966.52%
2011-06-30-18487.25%
2010-09-30-22578.39%

Annual Net Margin

DateNet Margin
2025-12-318.87%
2024-12-31-3.01%
2023-12-313.86%
2022-12-31-15.14%
2021-12-31-19.71%
2020-12-31-10.82%
2019-12-312.95%
2018-12-317.69%
2017-12-31-0.61%
2016-12-313.06%
2015-12-3120.14%
2014-12-3151.36%
2013-12-311.00%
2012-12-31-7.39%

Similar stocks

Stock NameCountryMarket CapPE Ratio
COMPASS Pathways plc (CMPS)$1.812B-4.87
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Biohaven Ltd. (BHVN)United States$1.990B-3.83